Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

100.0%

4 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05694247Not ApplicableTerminated

Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness

Role: lead

NCT04485858Not ApplicableTerminated

First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness

Role: lead

NCT05469867Not ApplicableTerminated

Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants

Role: lead

NCT04037917Not ApplicableTerminated

First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute

Role: lead

All 4 trials loaded